Rune Labs

Rune Labs is a San Francisco-based neurotechnology company building software infrastructure for neural data collected from implanted neurostimulators. The company's flagship platform, StrivePD, integrates neural biomarkers captured from devices such as Medtronic's Percept PC deep brain stimulator with continuous wearable sensor data to create a comprehensive picture of a patient's neurological state. By combining brain signal data with movement and symptom tracking, StrivePD enables clinicians to make more precise, data-driven decisions when programming and adjusting therapies for Parkinson's disease patients. The platform effectively bridges the gap between the raw electrophysiological data produced by implanted devices and the clinical workflows needed to act on that data meaningfully.

Rune Labs has established itself as an early mover in the emerging field of neural data infrastructure, securing a $22 million Series A funding round to accelerate its platform development and clinical adoption. The company has built partnerships with leading medical device manufacturers and academic medical centers, positioning StrivePD as a real-world evidence and care optimization tool within the Parkinson's treatment ecosystem. Its platform has been used to collect and analyze longitudinal neural data at a scale that was previously unavailable outside of controlled research settings. These milestones reflect growing recognition from both the clinical and investor communities that software-driven data intelligence will be central to the next generation of neuromodulation therapy.

Rune Labs represents a critical layer of infrastructure in the broader neurotechnology stack, addressing one of the field's most persistent challenges: translating raw neural data into actionable clinical insight. As implantable neurostimulators become increasingly sophisticated and capable of continuous brain sensing, the need for platforms that can aggregate, interpret, and contextualize that data will only grow. The company's approach also signals an important industry shift toward closed-loop and data-informed neuromodulation, where therapy is continuously refined rather than statically programmed. In this respect, Rune Labs is not only advancing care for Parkinson's patients today but helping to define the data infrastructure that will underpin precision neurology more broadly.